Evidence map›Paper›PMID 20652490›Full record

ReviewMolecules and cells2010

Reactive oxygen species in TNFalpha-induced signaling and cell death.

Michael J Morgan, Zheng-Gang Liu

Open access · greenAbstract readReview
In one paragraph

Review in Molecules and cells, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 3 pooled it
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 3 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Protection byPharmaceuticals (Basel, Switzerland) · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Biocompatible Copolymerized Gold Nanoclusters: Anti-Biomimetics (Basel, Switzerland) · 2025
    Article
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michael J MorganCell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Zheng-Gang Liu
Center for Cancer Research · USNational Institutes of Health · US

Funding

TNF Signaling, Cell Death and CancerZIASC010376 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI LIU, ZHENG-GANG · 2009 to 2025
$22.1M
The Molecular Mechanism of TNF-induced Necrotic Cell DeathZIABC010783 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LIU, ZHENG-GANG · 2009 to 2025
$9.5M
Molecular Mechanism of TNF Signaling and ApoptosisZ01SC010376 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI LIU, ZHENG-GANG · 2001 to 2008
$1.8M
Intramural NIH HHS Z01 SC010376
6 · The paper itself

Abstract

TNFalpha is a pleotropic cytokine that initiates many downstream signaling pathways, including NF-kappaB activation, MAP kinase activation and the induction of both apoptosis and necrosis. TNFalpha has shown to lead to reactive oxygen species generation through activation of NADPH oxidase, through mitochondrial pathways, or other enzymes. As discussed, ROS play a role in potentiation or inhibition of many of these signaling pathways. We particularly discuss the role of sustained JNK activation potentiated by ROS, which generally is supportive of apoptosis and "necrotic cell death" through various mechanisms, while ROS could have inhibitory or stimulatory roles in NF-kappaB signaling.

Indexed as

AnimalsApoptosisCell DeathHumansReactive Oxygen SpeciesSignal TransductionTumor Necrosis Factor-alphaReactive Oxygen SpeciesTumor Necrosis Factor-alpha

Identifiers

PMID20652490
PMCPMC6608586
OpenAlexW1980447537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.